Lunch Program: Influencing VTE Treatment Decisions: Evidence Supporting Catheter-based Interventions
Sponsored by Inari Medical.
This session will include discussion on current risk stratification of pulmonary embolism. It will also include the latest data available from FLASH, FLAME and CLOUT registries. The session will also cover results from FLAME, the largest prospective study of interventional treatment in high-risk PE, and provide updates on Inari’s RCTs: PEERLESS, PEERLESS II, and DEFIANCE.
PE and DVT cases will be discussed to understand how FlowTriever and ClotTriever have enabled the transition of treatment for these diseases from lytics to mechanical thrombectomy.